Page 23 - Heca News Today

Proxy advisory firm Institutional Shareholder Services (ISS) on Friday backed only one of Carl Icahn's three nominees to Illumina Inc's board, saying that the activist investor's push to remove the company's CEO was too disruptive.

The Group of Seven (G7) rich nations is set to agree on establishing a new program to distribute vaccines to developing countries at next week's summit of leaders, Japan's Yomiuri newspaper said on Saturday.

North Carolina Democratic Governor Roy Cooper said he would hold a rally on Saturday to highlight his planned veto of a bill that would ban most abortions after 12 weeks, a move the state's Republican-controlled legislature is expected to quickly vote to override.

Clarksville, TN - Yancy Villa, the 2022-23 recipient of the Austin Peay State University (APSU) Center of Excellence for the Creative Arts (CECA)

Argentine biotech firm Bioceres will expand sales of its HB4 wheat seeds, which harness the power of genetically-modified organisms (GMO), to dozens of seed companies to boost future sales of the drought-tolerant product, Bioceres said on Thursday.

Dutch medical device maker Philips will pay more than $62 million to resolve charges that it violated the Foreign Corrupt Practices Act over its conduct related to sales of medical equipment to China, the U.S. Securities and Exchange Commission said on Thursday.

New highly-effective weight loss drugs such as Novo Nordisk's Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.

British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about 804 million pounds ($1 billion), the company said.

Gaza resident Dina El-Dhani was due to meet her oncologist this week at a hospital in Jerusalem but she has been unable to cross into Israel since the border was closed amid heavy fighting between Israel and Palestinian militants.

The U.S. Food and Drug Administration approved Otsuka Pharmaceutical's brexpiprazole to treat agitation in patients with Alzheimer's on Thursday, making it the first approved drug for the indication, the company said in a statement.